{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:29:54Z","timestamp":1763767794584},"reference-count":27,"publisher":"Japanese Society of Toxicology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2023]]},"DOI":"10.2131\/jts.48.645","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T22:24:11Z","timestamp":1701383051000},"page":"645-654","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular safety pharmacology of ivermectin assessed using the isoflurane-anesthetized beagle dogs: ICH S7B follow-up study"],"prefix":"10.2131","volume":"48","author":[{"given":"Nobuyuki","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"},{"name":"Division of Cellular Physiology, Department of Physiology, Toho University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko T","family":"Naito","sequence":"additional","affiliation":[{"name":"Division of Cellular Physiology, Department of Physiology, Toho University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Buonfrate, D., Chesini, F., Martini, D., Roncaglioni, M.C., Ojeda Fernandez, M.L., Alvisi, M.F., De Simone, I., Rulli, E., Nobili, A., Casalini, G., Antinori, S., Gobbi, M., Campoli, C., Deiana, M., Pomari, E., Lunardi, G., Tessari, R. and Bisoffi, Z. (2022): High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial. Int. J. Antimicrob. Agents, <b>59<\/b>, 106516.","DOI":"10.1016\/j.ijantimicag.2021.106516"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Caly, L., Druce, J.D., Catton, M.G., Jans, D.A. and Wagstaff, K.M. (2020): The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 <i>in vitro.<\/i> Antiviral Res., <b>178<\/b>, 104787.","DOI":"10.1016\/j.antiviral.2020.104787"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cao, X., Nakamura, Y., Wada, T., Izumi-Nakaseko, H., Ando, K. and Sugiyama, A. (2016): Electropharmacological effects of amantadine on cardiovascular system assessed with J-T<sub>peak<\/sub> and T<sub>peak<\/sub>-T<sub>end<\/sub> analysis in the halothane-anesthetized beagle dogs. J. Toxicol. Sci., <b>41<\/b>, 439-447.","DOI":"10.2131\/jts.41.439"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Conterno, L.O., Turchi, M.D., Corr\u00eaa, I. and Monteiro de Barros Almeida, R.A. (2020): Anthelmintic drugs for treating ascariasis. Cochrane Database Syst. Rev., <b>4<\/b>, CD010599.","DOI":"10.1002\/14651858.CD010599.pub2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Coscione, S., Esau, T., Kekeubata, E., Diau, J., Asugeni, R., MacLaren, D., Steer, A.C., Kositz, C. and Marks, M. (2018): Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands. PLoS Negl. Trop. Dis., <b>12<\/b>, e0006825.","DOI":"10.1371\/journal.pntd.0006825"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Goa, K.L., McTavish, D. and Clissold, S.P. (1991): Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs, <b>42<\/b>, 640-658.","DOI":"10.2165\/00003495-199142040-00007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gokbulut, C., Cirak, V.Y., Senlik, B., Aksit, D., Durmaz, M. and McKellar, Q.A. (2010): Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses. Vet. Parasitol., <b>170<\/b>, 120-126.","DOI":"10.1016\/j.vetpar.2010.01.041"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Goto, A., Kambayashi, R., Izumi-Nakaseko, H., Shinozaki, M., Takei, Y. and Sugiyama, A. (2023): Characterization of electropharmacological profile of an anti-atrial fibrillatory drug vernakalant along with potential risk toward torsade de pointes: translational studies using isoflurane-anesthetized dogs and isolated rat aortic preparations. J. Pharmacol. Sci., <b>152<\/b>, 201-209.","DOI":"10.1016\/j.jphs.2023.05.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Heidary, F. and Gharebaghi, R. (2020): Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. J. Antibiot. (Tokyo), <b>73<\/b>, 593-602.","DOI":"10.1038\/s41429-020-0336-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Johannesen, L., Vicente, J., Mason, J.W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., S\u00f8rensen, J.S., Galeotti, L., Florian, J., Ugander, M., Stockbridge, N. and Strauss, D.G. (2014): Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Clin. Pharmacol. Ther., <b>96<\/b>, 549-558.","DOI":"10.1038\/clpt.2014.155"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kauthale, R.R., Dadarkar, S.S., Husain, R., Karande, V.V. and Gatne, M.M. (2015): Assessment of temperature-induced hERG channel blockade variation by drugs. J. Appl. Toxicol., <b>35<\/b>, 799-805.","DOI":"10.1002\/jat.3074"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kinobe, R.T. and Owens, L. (2021): A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin\u2019s possible mode of action against SARS-CoV-2. Fundam. Clin. Pharmacol., <b>35<\/b>, 260-276.","DOI":"10.1111\/fcp.12644"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kitahara, K., Nakamura, Y., Tsuneoka, Y., Adachi-Akahane, S., Tanaka, H., Yamazaki, H., Takahara, A., Yamazaki, J., Ikeda, T. and Sugiyama, A. (2013): Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir <i>in vivo<\/i> and <i>in vitro.<\/i> Cardiovasc. Toxicol., <b>13<\/b>, 234-243.","DOI":"10.1007\/s12012-013-9202-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kondo, Y., Hagiwara-Nagasawa, M., Kambayashi, R., Goto, A., Chiba, K., Nunoi, Y., Izumi-Nakaseko, H., Matsumoto, A. and Sugiyama, A. (2020): Electropharmacological characterization of aciclovir in the halothane-anesthetized dogs: A proposal of evaluation method for cardiovascular safety pharmacology of anti-virus drugs. Cardiovasc. Toxicol., <b>20<\/b>, 419-426.","DOI":"10.1007\/s12012-020-09568-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Molyneux, D.H. and Ward, S.A. (2015): Reflections on the Nobel Prize for Medicine 2015\u2013The public health legacy and impact of avermectin and artemisinin. Trends Parasitol., <b>31<\/b>, 605-607.","DOI":"10.1016\/j.pt.2015.10.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nagueh, S.F., Sun, H., Kopelen, H.A., Middleton, K.J. and Khoury, D.S. (2001): Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J. Am. Coll. Cardiol., <b>37<\/b>, 278-285.","DOI":"10.1016\/S0735-1097(00)01056-1"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Nakanishi, A., Okumura, H., Hashita, T., Yamashita, A., Nishimura, Y., Watanabe, C., Kamimura, S., Hayashi, S., Murakami, S., Ito, K., Iwao, T., Ikeda, A., Hirose, T., Sunazuka, T., Tanaka, Y. and Matsunaga, T. (2022): Ivermectin inhibits HBV entry into the nucleus by suppressing KPNA2. Viruses, <b>14<\/b>, 2468.","DOI":"10.3390\/v14112468"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Okonkwo, P.O., Ogbuokiri, J.E., Ofoegbu, E. and Klotz, U. (1993): Protein binding and ivermectin estimations in patients with onchocerciasis. Clin. Pharmacol. Ther., <b>53<\/b>, 426-430.","DOI":"10.1038\/clpt.1993.46"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Saito, H., Kambayashi, R., Hagiwara-Nagasawa, M., Nunoi, Y., Goto, A., Izumi-Nakaseko, H., Kawai, S., Takei, Y., Matsumoto, A., Hoshiai, K., Akie, Y. and Sugiyama, A. (2021a): In vivo comparison of <i>dl<\/i>-sotalol-induced electrocardiographic responses among halothane anesthesia, isoflurane anesthesia with nitrous oxide, and conscious state. J. Pharmacol. Sci., <b>145<\/b>, 16-22.","DOI":"10.1016\/j.jphs.2020.10.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Saito, H., Kambayashi, R., Goto, A., Hagiwara-Nagasawa, M., Hoshiai, K., Nunoi, Y., Izumi-Nakaseko, H., Akie, Y., Takei, Y., Matsumoto, A. and Sugiyama, A. (2021b): In vivo analysis of concentration-dependent effects of halothane or isoflurane inhalation on the electrocardiographic and hemodynamic variables in dogs. J. Pharmacol. Sci., <b>145<\/b>, 268-272.","DOI":"10.1016\/j.jphs.2020.12.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Sparsa, A., Bonnetblanc, J.M., Peyrot, I., Loustaud-Ratti, V., Vidal, E. and B\u00e9dane, C. (2006): Systemic adverse reactions with ivermectin treatment of scabies. Ann. Dermatol. Venereol., <b>133<\/b>, 784-787.","DOI":"10.1016\/S0151-9638(06)71044-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Sugiyama, A. and Hashimoto, K. (2002): Effects of a typical I(<sub>Kr<\/sub>) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes. Jpn. J. Pharmacol., <b>88<\/b>, 414-421.","DOI":"10.1254\/jjp.88.414"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Sugiyama, A. (2008): Sensitive and reliable proarrhythmia <i>in vivo<\/i> animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br. J. Pharmacol., <b>154<\/b>, 1528-1537.","DOI":"10.1038\/bjp.2008.240"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sugiyama, A., Satoh, Y. and Hashimoto, K. (2001): Acute electropharmacological effects of intravenously administered amiodarone assessed in the <i>in vivo<\/i> canine model. Jpn. J. Pharmacol., <b>87<\/b>, 74-82.","DOI":"10.1254\/jjp.87.74"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Strauss, D.G., Wu, W.W., Li, Z., Koerner, J. and Garnett, C. (2021): Translational models and tools to reduce clinical trials and improve regulatory decision making for QTc and proarrhythmia risk (ICH E14\/S7B updates). Clin. Pharmacol. Ther., <b>109<\/b>, 319-333.","DOI":"10.1002\/cpt.2137"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Van de Water, A., Verheyen, J., Xhonneux, R. and Reneman, R.S. (1989): An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J. Pharmacol. Methods, <b>22<\/b>, 207-217.","DOI":"10.1016\/0160-5402(89)90015-6"},{"key":"27","unstructured":"WHO Health Organization. (1987): WHO Expert Committee on onchocerciasis. Third report. World Health Organ. Tech. Rep. Ser., <b>752<\/b>, 1-167."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/48\/12\/48_645\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:57:49Z","timestamp":1715576269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/48\/12\/48_645\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.48.645","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}